Skip to main navigation Skip to search Skip to main content

ASHP statement on the pharmacy and therapeutics committee and the formulary system

  • Daniel T. Abazia
  • , Philip Anderson
  • , Lilian M. Azzopardi
  • , Kenneth R. Baker
  • , James L. Besier
  • , J. Lyle Bootman
  • , David G. Bowyer
  • , Maureen Brady
  • , Margaret Chrymko
  • , Joseph W. Cranston
  • , Steven Dzierba
  • , Michael Gaunt
  • , Pamela C. Hagan
  • , Raymond W. Hammond
  • , Eric T. Hola
  • , Patricia Kienle
  • , Katharine Kiser
  • , Thomas L. Kurt
  • , Timothy R. Lanese
  • , Rosario J. Lazzaro
  • Melvin E. Liter, Patrick M. Malone, Candis M. Morello, Richard O'Brocta, Folakemi T. Odedina, James A. Ponto, Curt W. Quap, Mike Rouse, Marissa Schlaifer, Shelley Hoppe Schliesser, Michele F. Shepherd, Jonalan Smith, Allen J. Vaida, William E. Wade, Tom W. Woller, John L. Woon

Research output: Contribution to journalArticlepeer-review

30 Scopus citations
Original languageEnglish
Pages (from-to)2384-2386
Number of pages3
JournalAmerican Journal of Health-System Pharmacy
Volume65
Issue number24
DOIs
StatePublished - Dec 15 2008

Keywords

  • American Society of Health-System Pharmacists
  • Formulary system
  • Guidelines
  • Organizations
  • Pharmacy and therapeutics committee
  • Pharmacy, institutional, hospital

Fingerprint

Dive into the research topics of 'ASHP statement on the pharmacy and therapeutics committee and the formulary system'. Together they form a unique fingerprint.

Cite this